NEW YORK: The United States Food and Drug Administration’s (FDA) authorization of marketing of modified risk tobacco products (MRTPs) should encourage other countries to take a second look at innovative products as effective means to eradicate the smoking epidemic, according to two public health experts.

Prof. Tom Glynn, an adjunct lecturer at Stanford Prevention Research Center and a former director of International Cancer Control at the American Cancer Society in Washington D.C., said heat-not-burn tobacco products (HTPs) such as IQOS, electronic cigarettes and other less harmful products provide smokers with better alternatives to cigarettes.

Premium + Digital Edition

Ad-free access


P 80 per month
(billed annually at P 960)
  • Unlimited ad-free access to website articles
  • Limited offer: Subscribe today and get digital edition access for free (accessible with up to 3 devices)

TRY FREE FOR 14 DAYS
See details
See details